Boundless exploration: Dive into the future of research
Revolutionize your research with the SpectraMax i3x Multi-Mode Microplate Reader. Western blotting, cell imaging, and MicroVolume DNA/RNA quantitation in one state-of-the-art platform
Discover infinite possibilities in research with the SpectraMax® i3x Multi-Mode Microplate Reader – a masterpiece that evolves as your scientific curiosity grows. Unlock a new dimension of versatility as you tap into spectral-based absorbance, fluorescence, and luminescence. Dive deeper with modular upgrades, capturing cellular pathways, protein activations, and more – all in one sophisticated system. Experience unprecedented sensitivity across the spectrum with our Spectral Fusion Illumination and delve into quantitative low-light measurements like never before, courtesy of our cooled PMT. And when innovation calls, amplify your research capabilities in mere seconds with user-exchangeable detection modules. The SpectraMax i3x can be upgraded in the field to include western blot, cell imaging, and fast kinetics with injectors plus additional detection modes, and like all of our readers, comes with the unparalleled SoftMax Pro Software, turning every research avenue into a promising horizon. Empower your research journey today and shape tomorrow with the SpectraMax i3x – where potential meets precision.
Future-Ready Flexibility
Modular upgrades that grow with your research needs and can be done in the field saving you time and money.
Engineered Excellence
Dynamic range auto-intensity adjustment, superior fluorescence performance, and effortless application enhancement.
GxP Compliance Ready
With our IQ/OQ/PM Services and SoftMax Pro GxP Software, qualify and preserve your documentation in a compliant format that can be accessed remotely. Our extensive suite of validation tools reduces the cost and time of validation by 50% compared to multiple platforms.
Customer breakthrough
John Gibson, PhD, FAHA Yimei Yue, Research Associate
Ionic Transport Assays uses the SpectraMax i3 reader to study drug candidate-induced cardiotoxicity in stem cell-derived cardiomyocytes
Ionic Transport Assays Inc. is a contract research organization located in St Louis, MO. Since 2011, Ionic Transport Assays has performed multiple assays for customers on human induced pluripotent stem cell cardiomyocytes (hIPSC–CM). This work is directed to meet the challenges of the Safety Pharmacology Comprehensive in vitro Proarrhythmia Assessment (CiPA) proposed by the FDA for new drug development.
*Price, time to deliver, and specifications will vary based on mutually agreed technical requirements. Solution requirements may cause adjustment to standard performance.